Florian Reinaud
Director/Board Member bei SENSORION
Profil
Florian Nicolas Christian Reinaud is currently a Director at Sensorion SA and Sensome SAS.
He previously worked as a Director at Kuros Biosurgery Holding AG, Zealand Pharma A, Praxim SA, Voluntis SA, OMNI Orthopaedics, Inc., and FAB Pharma SAS.
Florian also worked as an Investment Manager at Amboise Partners SA, an Analyst at Schroder Salomon Smith Barney, and a General Partner at Innovation Capital SASU.
He was also the Chief Financial Officer at DBV Technologies SA and an Analyst at Schroder Salomon Smith Barney International Ltd.
Florian received his undergraduate degree from the University of Oxford and his doctorate from Imperial College London.
Aktive Positionen von Florian Reinaud
| Unternehmen | Position | Beginn |
|---|---|---|
| SENSORION | Director/Board Member | - |
Sensome SAS
 Sensome SAS Electronic Equipment/InstrumentsElectronic Technology Sensome SAS develops remote monitoring invasive vascular medical devices. It focuses on turning invasive medical devices into connected healthcare devices. The company was founded by Franz Bozsak and Abdul Barakat and is headquartered in Massy, France. | Director/Board Member | 01.06.2017 |
Ehemalige bekannte Positionen von Florian Reinaud
| Unternehmen | Position | Ende |
|---|---|---|
Innovation Capital SASU
 Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | Private Equity Investor | 30.07.2015 |
Amboise Partners SA
 Amboise Partners SA Investment ManagersFinance Apax Partners SA operates as a private equity firm. It invests in technology, media, telecom, retail, healthcare, and business and financial services industries. The company was founded by Maurice Tchenio and Ronald Cohen in 1972 and is headquartered in France. | Private Equity Investor | 01.01.2008 |
| Schroder Salomon Smith Barney International Ltd. | Analyst-Equity | 19.05.2003 |
| VOLUNTIS S.A. | Director/Board Member | - |
OMNI Orthopaedics, Inc.
 OMNI Orthopaedics, Inc. Medical SpecialtiesHealth Technology OMNI Orthopaedics, Inc. designs, manufactures, and distributes orthopedic implants. The company was founded by David L. Lasalle, George B. Cipoletti and Edward J. Cheal on December 22, 2008 and is headquartered in Taunton, MA. | Director/Board Member | - |
Ausbildung von Florian Reinaud
| University of Oxford | Undergraduate Degree |
| Imperial College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| SENSORION | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Amboise Partners SA
Amboise Partners SA Investment ManagersFinance Apax Partners SA operates as a private equity firm. It invests in technology, media, telecom, retail, healthcare, and business and financial services industries. The company was founded by Maurice Tchenio and Ronald Cohen in 1972 and is headquartered in France. | Finance |
| Schroder Salomon Smith Barney | Finance |
Kuros Biosurgery Holding AG
 Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Commercial Services |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | Finance |
Praxim SA
 Praxim SA Medical SpecialtiesHealth Technology Praxim SA manufactures and sells orthopedic surgical instruments. It specializes in minimal invasive products for knee arthroscopy. The company was founded by Stéphane Lavallée in 1995 and is headquartered in La Tronche, France. | Health Technology |
| Schroder Salomon Smith Barney International Ltd. | Finance |
Voluntis SA
 Voluntis SA Packaged SoftwareTechnology Services Voluntis SA develops and markets software solutions for the healthcare industry. The firm specializes in patient relationship management software suited for pharmaceutical, medical devices, and health networks applications. It offers patient monitoring and support programs; mobile data collection; medical device development software; training; and consulting services. The company was founded by Romain Marmot, Etienne Vial, and Pierre Leurent in 2001 and is headquartered in Suresnes, France. | Technology Services |
OMNI Orthopaedics, Inc.
OMNI Orthopaedics, Inc. Medical SpecialtiesHealth Technology OMNI Orthopaedics, Inc. designs, manufactures, and distributes orthopedic implants. The company was founded by David L. Lasalle, George B. Cipoletti and Edward J. Cheal on December 22, 2008 and is headquartered in Taunton, MA. | Health Technology |
FAB Pharma SAS
 FAB Pharma SAS Miscellaneous Commercial ServicesCommercial Services FAB Pharma SAS operates as a biopharmaceutical company. It develops drugs for the treatment of bacterial infections. It also provides pharmaceutical research services. It focuses on therapeutics addressing current antibiotics resistance issues to control severe bacterial infections. Its products are drugs with low-molecular-weight antibacterial molecules for enzymes in Fatty Acid Biosynthesis I. The company was founded by Stefan Fischer on June 15, 2009 and is headquartered in Paris, France. | Commercial Services |
Sensome SAS
Sensome SAS Electronic Equipment/InstrumentsElectronic Technology Sensome SAS develops remote monitoring invasive vascular medical devices. It focuses on turning invasive medical devices into connected healthcare devices. The company was founded by Franz Bozsak and Abdul Barakat and is headquartered in Massy, France. | Electronic Technology |
